/wp-content/uploads/2021/05/HU-featured-image-Press-Release-052421.jpg
840
2202
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2021-05-25 17:03:362021-08-02 12:33:06Understanding Barriers To Needed Access to HCP, Specialist CareHealth Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.
/wp-content/uploads/2021/05/HU-featured-image-Press-Release-052421.jpg
840
2202
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2021-05-25 17:03:362021-08-02 12:33:06Understanding Barriers To Needed Access to HCP, Specialist Care
/wp-content/uploads/2021/05/HU-featured-image-Press-Release-042621.jpg
840
2202
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2021-05-04 09:47:182021-05-25 17:06:32Is Tech the Secret to Controlling Asthma Flare-Ups?
/wp-content/uploads/2021/04/HU-linkedin-blog-mobie-042021.jpg
628
1200
Felicia Brecher
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Felicia Brecher2021-04-26 11:02:492021-05-04 12:54:273 Considerations for Pharma Brand Strategy Success
/wp-content/uploads/2021/04/HU-featured-image-Press-Release-041521.jpg
840
2202
Stephen Wilson
/wp-content/uploads/2021/06/health-union-logo-07-300x90-1.png
Stephen Wilson2021-04-16 10:35:062021-04-26 11:03:35Mitigating the Misdiagnosis JourneyUnderstanding Barriers To Needed Access to HCP, Specialist Care
For a number of reasons, people don’t always have access to the HCPs most attuned to their needs, which presents hurdles throughout their health journey.
Is Tech the Secret to Controlling Asthma Flare-Ups?
Survey findings suggest there are early adopters using tech to manage their asthma symptoms. Half of respondents are interested in using a digital inhaler.
3 Considerations for Pharma Brand Strategy Success
As the digital landscape evolves and third-party cookies disappear, keep the following considerations in mind for your pharma brand strategy.
Mitigating the Misdiagnosis Journey
Nearly half of IBD In America 2020 respondents living with Crohn’s disease said they were previously misdiagnosed during their diagnosis journey.